Cystic Fibrosis and Abnormal Lung Function
Changes in lung function are of critical importance to patients with cystic fibrosis (CF), as lung function is a key indicator of disease progression and treatment effectiveness.
Tag: Percussionaire
All
Latest
Cystic Fibrosis and Abnormal Lung Function
Changes in lung function are of critical importance to patients with cystic fibrosis (CF), as lung function is a key indicator of disease progression and treatment effectiveness.
Read More
Recall for Certain Phasitron Breathing Circuits from Sentec/Percussionaire
Sentec/Percussionaire is recalling Phasitron breathing circuit kits after receiving a customer complaint that the venturi component of the kit may stop oscillating during use, resulting in patient oxygen desaturation, according to an FDA alert.
Read More
Percussionaire Removes Certain Phasitron 5 Breathing Circuits
The FDA has issued a Class I recall for certain lots of Percussionaire’s Phasitron 5 breathing circuits.
Read More
Use Instructions Revised for Phasitron 5 IPV Therapy Device to Prevent Patient Harm
Sentec/Percussionaire has updated use instructions for Phasitron 5 In-Line Valve to prevent accidental misuse of expiratory port plug.
Read More
Percussionaire Recalls Phasitron Breathing Circuit Kits Due to Over-pressurization
The use of the affected Phasitron kits may cause serious adverse health consequences, including lung injury, low blood pressure, collapsed lung, cardiac arrest, and death.
Read More
IPV Therapy: An Essential Solution for Secretion Clearance and Atelectasis
Retained and excessive secretions can lead to disorders like atelectasis but therapies like Percussionaire’s IPV therapy—recently acquired by Sentec—can improve patient outcomes.
Read More
Sentec Acquires Percussionaire
Sentec has acquired Percussionaire, a specialty ventilation company founded by respiratory device innovator Dr. Forrest Bird.
Read More